GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CAS Medical Systems Inc (NAS:CASM) » Definitions » Piotroski F-Score

CAS Medical Systems (CAS Medical Systems) Piotroski F-Score : 0 (As of May. 03, 2024)


View and export this data going back to 1995. Start your Free Trial

What is CAS Medical Systems Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

CAS Medical Systems has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for CAS Medical Systems's Piotroski F-Score or its related term are showing as below:


CAS Medical Systems Piotroski F-Score Historical Data

The historical data trend for CAS Medical Systems's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CAS Medical Systems Piotroski F-Score Chart

CAS Medical Systems Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 4.00 3.00 4.00 4.00

CAS Medical Systems Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 4.00 4.00 4.00 4.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec18) TTM:Last Year (Dec17) TTM:
Net Income was -1.418 + -1.715 + -1.283 + -1.545 = $-5.96 Mil.
Cash Flow from Operations was -0.12 + -1.06 + -1.179 + -0.273 = $-2.63 Mil.
Revenue was 5.444 + 5.291 + 5.382 + 5.802 = $21.92 Mil.
Gross Profit was 3.087 + 3.181 + 3.14 + 3.299 = $12.71 Mil.
Average Total Assets from the begining of this year (Dec17)
to the end of this year (Dec18) was
(12.975 + 11.658 + 12.688 + 11.734 + 10.85) / 5 = $11.981 Mil.
Total Assets at the begining of this year (Dec17) was $12.98 Mil.
Long-Term Debt & Capital Lease Obligation was $9.24 Mil.
Total Current Assets was $8.09 Mil.
Total Current Liabilities was $3.47 Mil.
Net Income was -1.844 + -2.106 + 3.089 + -1.476 = $-2.34 Mil.

Revenue was 5.225 + 4.572 + 4.526 + 5.121 = $19.44 Mil.
Gross Profit was 2.844 + 2.378 + 2.644 + 2.754 = $10.62 Mil.
Average Total Assets from the begining of last year (Dec16)
to the end of last year (Dec17) was
(14.724 + 13.223 + 12.001 + 14.362 + 12.975) / 5 = $13.457 Mil.
Total Assets at the begining of last year (Dec16) was $14.72 Mil.
Long-Term Debt & Capital Lease Obligation was $4.94 Mil.
Total Current Assets was $10.00 Mil.
Total Current Liabilities was $5.20 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

CAS Medical Systems's current Net Income (TTM) was -5.96. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

CAS Medical Systems's current Cash Flow from Operations (TTM) was -2.63. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec17)
=-5.961/12.975
=-0.45942197

ROA (Last Year)=Net Income/Total Assets (Dec16)
=-2.337/14.724
=-0.15872046

CAS Medical Systems's return on assets of this year was -0.45942197. CAS Medical Systems's return on assets of last year was -0.15872046. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

CAS Medical Systems's current Net Income (TTM) was -5.96. CAS Medical Systems's current Cash Flow from Operations (TTM) was -2.63. ==> -2.63 > -5.96 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec18)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec17 to Dec18
=9.24/11.981
=0.7712211

Gearing (Last Year: Dec17)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec16 to Dec17
=4.943/13.457
=0.36731812

CAS Medical Systems's gearing of this year was 0.7712211. CAS Medical Systems's gearing of last year was 0.36731812. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec18)=Total Current Assets/Total Current Liabilities
=8.087/3.473
=2.32853441

Current Ratio (Last Year: Dec17)=Total Current Assets/Total Current Liabilities
=10.001/5.198
=1.92400923

CAS Medical Systems's current ratio of this year was 2.32853441. CAS Medical Systems's current ratio of last year was 1.92400923. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

CAS Medical Systems's number of shares in issue this year was 27.884. CAS Medical Systems's number of shares in issue last year was 27.351. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=12.707/21.919
=0.57972535

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=10.62/19.444
=0.54618391

CAS Medical Systems's gross margin of this year was 0.57972535. CAS Medical Systems's gross margin of last year was 0.54618391. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec17)
=21.919/12.975
=1.68932563

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec16)
=19.444/14.724
=1.32056506

CAS Medical Systems's asset turnover of this year was 1.68932563. CAS Medical Systems's asset turnover of last year was 1.32056506. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+1+0+1+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

CAS Medical Systems has an F-score of 4 indicating the company's financial situation is typical for a stable company.

CAS Medical Systems  (NAS:CASM) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


CAS Medical Systems Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of CAS Medical Systems's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


CAS Medical Systems (CAS Medical Systems) Business Description

Traded in Other Exchanges
N/A
Address
44 East Industrial Road, Branford, CT, USA, 06405
CAS Medical Systems Inc is a medical technology company that develops, manufactures, and markets non-invasive patient monitoring products. The company's products are the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. .
Executives
Alan Milinazzo director C/O ORTHOFIX INC, 10115 KINCEY AVENUE STE 250, HUNTERSVILLE NC 28078
Thomas M Patton director, officer: President and CEO C/O OSTEOTCH INC., 51 JAMES WAY, EATONTOWN NJ 07724
Kenneth R Weisshaar director 875 PARK AVE APT 2D, NEW YORK NY 10021
James E Thomas director, 10 percent owner WOODS END ROAD, NEW CANAAN CT 06840
Thomas, Mcnerney & Partners Ii L.p. 10 percent owner 45 SOUTH 7TH STREET, SUITE 3060, Minneapolis MN 55402
Tmp Associates Ii Lp 10 percent owner 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Tmp Nominee Ii, Llc 10 percent owner 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Thomas, Mcnerney & Partners Ii, Llc 10 percent owner 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Acuta Capital Fund, Lp 10 percent owner 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002
James E Flynn 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Management Company, L.p. (series C) 10 percent owner, other: Possible Member of 10% Group 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Deerfield Mgmt L.p. 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Special Situations Fund, L.p. 10 percent owner, other: Possible Member of 10% Group 780 3RD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Special Situations International Master Fund, L.p. 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Lawrence Burstein director C/O UNITY VENTURE CAPITAL ASSOCIATES LTD, 245 FIFTH AVENUE, SUITE 1500, NEW YORK NY 10016